Table 2.

Associations between FHL1 mRNA levels and clinical parameters in a training cohort (n = 40)

Characteristic	No. of patients (%)	FHL1 mRNA expression	P value (2-ΔCt Mean ± SD)
Age, y	40 (100)
≥60	31 (77.5)	2.440±2.266	0.137
< 60	9 (22.5)	1.237±1.214
Sex	40 (100)
Men	27 (67.5)	2.039±2.004	0.583
Women	13 (32.5)	2.440±2.417
Tumor size	40 (100)
≥5 cm	18 (45)	2.190±2.257	0.957
< 5 cm	22 (55)	2.153±2.047
Tumour location	40 (100)
Left hemicolon	34 (85)	2.178±2.108	0.951
Right hemicolon	6 (15)	2.120±2.418
pT stage	40 (100)
I-II	20 (50)	3.118±2.537	0.003
III-IV	20 (50)	1.221±0.964
Lymph node metastasis	40 (100)
pN positive	19 (47.5)	1.194±0.851	0.004
pN negative	21 (52.5)	3.053±2.534
Distant metastasis	40 (100)
pM positive	6 (15)	0.902±0.840	0.114
pM negative	34 (85)	2.393±2.209